1. Home
  2. AMPH vs AGX Comparison

AMPH vs AGX Comparison

Compare AMPH & AGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • AGX
  • Stock Information
  • Founded
  • AMPH 1996
  • AGX 1961
  • Country
  • AMPH United States
  • AGX United States
  • Employees
  • AMPH N/A
  • AGX N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • AGX Engineering & Construction
  • Sector
  • AMPH Health Care
  • AGX Consumer Discretionary
  • Exchange
  • AMPH Nasdaq
  • AGX Nasdaq
  • Market Cap
  • AMPH 1.7B
  • AGX 2.1B
  • IPO Year
  • AMPH 2014
  • AGX N/A
  • Fundamental
  • Price
  • AMPH $36.41
  • AGX $166.98
  • Analyst Decision
  • AMPH Buy
  • AGX Buy
  • Analyst Count
  • AMPH 4
  • AGX 3
  • Target Price
  • AMPH $60.33
  • AGX $123.33
  • AVG Volume (30 Days)
  • AMPH 672.6K
  • AGX 348.4K
  • Earning Date
  • AMPH 02-26-2025
  • AGX 12-05-2024
  • Dividend Yield
  • AMPH N/A
  • AGX 0.86%
  • EPS Growth
  • AMPH 17.38
  • AGX 92.83
  • EPS
  • AMPH 3.01
  • AGX 4.81
  • Revenue
  • AMPH $723,549,000.00
  • AGX $806,259,000.00
  • Revenue This Year
  • AMPH $16.76
  • AGX $47.84
  • Revenue Next Year
  • AMPH $8.00
  • AGX $6.90
  • P/E Ratio
  • AMPH $12.09
  • AGX $36.39
  • Revenue Growth
  • AMPH 20.33
  • AGX 52.83
  • 52 Week Low
  • AMPH $34.60
  • AGX $43.94
  • 52 Week High
  • AMPH $56.45
  • AGX $191.46
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 39.93
  • AGX 59.06
  • Support Level
  • AMPH $34.60
  • AGX $173.88
  • Resistance Level
  • AMPH $36.66
  • AGX $191.46
  • Average True Range (ATR)
  • AMPH 1.41
  • AGX 9.25
  • MACD
  • AMPH 0.29
  • AGX 1.73
  • Stochastic Oscillator
  • AMPH 43.54
  • AGX 59.54

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About AGX Argan Inc.

Argan Inc is a United States-base construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derive majority revenue.

Share on Social Networks: